These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2999958)

  • 1. Cost of tuberculosis chemotherapy.
    Pardon R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):167-8. PubMed ID: 2999958
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparison of the immediate results of intensive short-term antitubercular chemotherapy with those of the classic regimens lasting 9 months].
    Cioflec D; Boariu I; Dumitru V; Bobic A; Mihalache F; Mihalache D; Constantinescu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(3):261-8. PubMed ID: 2855672
    [No Abstract]   [Full Text] [Related]  

  • 3. [The efficacy and cost of treating patients with destructive pulmonary tuberculosis in a rural locality].
    Strakhov NS; Strutinskiĭ MI
    Vrach Delo; 1990 Apr; (4):73. PubMed ID: 2275177
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost of tuberculosis chemotherapy short-course regimens and care.
    Corlan E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):161-2. PubMed ID: 2999955
    [No Abstract]   [Full Text] [Related]  

  • 5. [The cost of pulmonary tuberculosis treatment in the Congo].
    M'Boussa J
    Med Trop (Mars); 1991; 51(1):81-5. PubMed ID: 2072854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitubercular agents].
    Dournovo P; Monteau D
    Soins; 1986 Dec; (491-492):35-7. PubMed ID: 3105081
    [No Abstract]   [Full Text] [Related]  

  • 7. Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?
    Lobato MN; Jereb JA; Castro KG
    Pediatrics; 2009 Mar; 123(3):902-3. PubMed ID: 19255018
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost of antituberculosis drug regimens in Morocco.
    Bartal M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):163-4. PubMed ID: 2999956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect and treatment problems of secondary antitubercular agents].
    Dissmann E
    Wien Med Wochenschr; 1966 Nov; 116(47):996-8. PubMed ID: 6011782
    [No Abstract]   [Full Text] [Related]  

  • 10. [Theoretical cost of the medical treatment of a case of tuberculosis in France in 1982].
    Pretet S; Lotte A; Marsac J; Choudat D
    Rev Fr Mal Respir; 1983; 11(5):677-85. PubMed ID: 6658154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modern treatment of pulmonary tuberculosis. I. Development of tuberculosis therapy in the last 30 years].
    Zegaya M
    Tunis Med; 1984 Sep; 62(5):335-43. PubMed ID: 6528417
    [No Abstract]   [Full Text] [Related]  

  • 12. [The cost of treatment in new case and multidrug resistant case in pulmonary tuberculosis].
    Kizkin O; Hacievliyagil SS; Türker G; Günen H
    Tuberk Toraks; 2003; 51(4):410-5. PubMed ID: 15143390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of drug cost for pulmonary tuberculosis patients. 2. Total drug cost].
    Tamura M; Tokioka T; Akiyama T; Niioka M; Uchida H
    Iryo; 1966 Nov; 20(11):1216-20. PubMed ID: 5982068
    [No Abstract]   [Full Text] [Related]  

  • 14. DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.
    Norval PY; San KK; Bakhim T; Rith DN; Ahn DI; Blanc L
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):44-51. PubMed ID: 9562110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the cause and result of over-treated in active pulmonary tuberculosis cases].
    Li YS
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Apr; 9(2):65-7, 125. PubMed ID: 3743285
    [No Abstract]   [Full Text] [Related]  

  • 16. Wrong drug used for tuberculosis.
    Kelly PM
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):385. PubMed ID: 9432398
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of drug cost for pulmonary tuberculosis patients. 1. Antituberculosis drugs].
    Tamura M; Tokioka T; Akiyama T; Niioka M; Uchida H
    Iryo; 1966 Nov; 20(11):1206-15. PubMed ID: 5982067
    [No Abstract]   [Full Text] [Related]  

  • 18. Expenses incurred by patients with tuberculosis prior to attending DOT centres.
    Ray TK; Sharma N; Singh MM; Ingle GK
    Natl Med J India; 2004; 17(4):227-8. PubMed ID: 15372778
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group.
    Migliori GB; Khomenko AG; Punga VV; Ambrosetti M; Danilova I; Ribka LN; Grzemska M; Sawert H; Raviglione MC
    Bull World Health Organ; 1998; 76(5):475-83. PubMed ID: 9868838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of controlled therapeutic trials. I. Short-term regimens. Conclusion].
    Chew CH
    Bull Int Union Tuberc; 1974; 49(1):418-9. PubMed ID: 4619562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.